Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FLJNA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,662
Award facts
- Contract value 100% obligated
- $30,661.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,661.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Kesimpta 20 mg/0.4 ml pens (a treatment for multiple sclerosis). The contract, which is not set-aside, is scheduled for completion by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, has demonstrated significant capability in fulfilling DLA requirements through competitive award of diverse pharmaceutical products and medical supplies. The company's existing IDC portfolio encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order for Kesimpta exemplifies the company's role in supplying specialized neurological treatments to support military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FLJNA?
SPE2DB25FLJNA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FLJNA worth?
The government has obligated $30,662 on SPE2DB25FLJNA.
Is contract SPE2DB25FLJNA an order under another contract?
Yes. SPE2DB25FLJNA is a delivery order under SPE2DB24D6044, an indefinite delivery contract.
Was contract SPE2DB25FLJNA competed?
The extent of competition for SPE2DB25FLJNA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award